1 |
권혜영, 양봉민 : 고정예산제를 활용한 외국의 약제비 관리와 시사점. 보건경제와 정책연구 17 (2011).
|
2 |
Comite Economique des Produits de Sante (CEPS) - Healthcare products pricing committee: Annual Report 2008, Paris (2009).
|
3 |
CEPS : Rapport annuel d'activite 2006, Comite economique des produits de sante, Paris (2007).
|
4 |
Cour des Comptes : La securite sociale, Paris (2004).
|
5 |
Delcroix-Lopes, S. : French Pharmaceutical system: Focus on pricing and reimbursement, PPRI Conference, Vienna (2011).
|
6 |
Durieux, P., Chaix-Couturier, C., Durand-Zaleski, I. and Ravaud, P. : From clinical recommendations to mandatory practice: the introduction of regulatory practice guidelines in the French healthcare system. International Journal of Technology Assessment in Health Care 16, 969 (2000).
DOI
ScienceOn
|
7 |
Grandfils, N. : Drug price setting and regulation in France, IRDES, Paris (2008).
|
8 |
Le Pen, C. : The Drug Budget Silo Mentality: The French Case. Value Health 6, S10 (2003).
DOI
ScienceOn
|
9 |
OBIG (Osterreichisches Bundesinstitut fur Gesundheitswesen) : Pharmaceutical Pricing and Reimbursement Information - France, Vienna (2008).
|
10 |
Corens, D. : Health Systems in Transition: Belgium Health System review (2007).
|
11 |
Eggermont, M. and Kanavos, P. : Pricing and Reimbursement in Belgium. London School of Economics and Political Science, London (2001).
|
12 |
Gerkens, S. and Merkur, S. : Health Systems in Transition, Belgium Health System Review (2010).
|
13 |
OBIG : Pharmaceutical Pricing and Reimbursement Information - Belgium, Vienna (2008).
|
14 |
Schokkaert, E. and Van de Voorde, C. : Health care reform in Belgium. Health Economics. 16, S25 (2005).
|
15 |
Donatini, A., Rico, A., D'Ambrosio, M. G., Scalzo, A. L., Orzella, L., Cicchetti, A. and Profili, S. : Health Care Systems in Transition: Italy, European Observatory on Health Care Systems, Copenhagen (2001).
|
16 |
Fattore, G. and Jommi, C. : The new pharmaceutical policy in Italy. Health Policy. 46, 21 (1998).
DOI
ScienceOn
|
17 |
Folino-Gallo, P., Montilla, S., Bruzzone, M. and Martini, N. : Pricing and reimbursement of pharmaceuticals in Italy. Eur. J. Health Econ. 9, 305 (2008).
DOI
|
18 |
Scalzo, A. L., Donatini, A., Orzella, L., Cicchetti, A., Profili, S. and Maresso, A. : Health Systems in Transition, Italy: Health System Review (2009).
|
19 |
Mapelli, V. and Lucioni, C. : Spending on Pharmaceuticals in Italy: Macro Constraints with Local Autonomy. Value in Health 6, 31 (2003).
DOI
ScienceOn
|
20 |
OBIG : Pharmaceutical Pricing and Reimbursement Information - Italy, Vienna (2007).
|
21 |
The Pharma Letter : Italian pharma overspending payback decree "threatens industry collapse", (2004-07-26). available at: http://www.thepharmaletter.com/file/48267/italian-pharma-overspending- payback-decree-threatens-industry-collapse. html.
|
22 |
OBIG/European Commission : Surveying, Assessing and Analysing the Pharmaceutical Sector in the 25 EU Member States, Vienna (2006).
|
23 |
Seiter, A. : Pharmaceutical Pricing and Reimbursement - A Global Perspective, PPRI Conference, Vienna (2011).
|
24 |
Vogler, S. : Pricing and reimbursement of medicines: A European overview, PPRI Conference, Vienna (2011).
|
25 |
Sood, N., De Vroes. H., Gutierrez, I., Lakdawalla, D. N. and Goldman, D. P. : The Effect of Regulation on Pharmaceutical Revenues: Experience In Nineteen Countries. Health Affairs. 28, w125 (2008).
|
26 |
이의경, 김성옥, 배정윤, 강현하, 김지연 : 약제비 적정화방안이 약국 및 제약업계에 미치는 영향 분석과 정책 대안, 숙명여자대학교/의약품정책연구소 (2007).
|